EPHA4 and amyotrophic lateral sclerosis: Given that mutEphA4-Fc can be regarded as a “pan-ephrin blocker” due to its ability to bind to both A and B type ephrins9, the blockade of many EphA4-ephrin interactions also cooperatively slow ALS progression.